6.
Schmidt H, Mietlicki-Baase E, Ige K, Maurer J, Reiner D, Zimmer D
. Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine. Neuropsychopharmacology. 2015; 41(7):1917-28.
PMC: 4869061.
DOI: 10.1038/npp.2015.362.
View
7.
Figlewicz D
. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat: Historical perspective. Brain Res. 2016; 1645:68-70.
DOI: 10.1016/j.brainres.2015.12.041.
View
8.
de Weijer B, van de Giessen E, Janssen I, Berends F, van de Laar A, Ackermans M
. Striatal dopamine receptor binding in morbidly obese women before and after gastric bypass surgery and its relationship with insulin sensitivity. Diabetologia. 2014; 57(5):1078-80.
PMC: 3980032.
DOI: 10.1007/s00125-014-3178-z.
View
9.
Edwin Thanarajah S, Iglesias S, Kuzmanovic B, Rigoux L, Stephan K, Bruning J
. Modulation of midbrain neurocircuitry by intranasal insulin. Neuroimage. 2019; 194:120-127.
DOI: 10.1016/j.neuroimage.2019.03.050.
View
10.
Naef L, Pitman K, Borgland S
. Mesolimbic dopamine and its neuromodulators in obesity and binge eating. CNS Spectr. 2015; 20(6):574-83.
DOI: 10.1017/S1092852915000693.
View
11.
Skibicka K, Hansson C, Alvarez-Crespo M, Friberg P, Dickson S
. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience. 2011; 180:129-37.
DOI: 10.1016/j.neuroscience.2011.02.016.
View
12.
Flegal K, Kit B, Orpana H, Graubard B
. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82.
PMC: 4855514.
DOI: 10.1001/jama.2012.113905.
View
13.
Volkow N, Wang G, Baler R
. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci. 2010; 15(1):37-46.
PMC: 3124340.
DOI: 10.1016/j.tics.2010.11.001.
View
14.
Pozzi M, Mazhar F, Peeters G, Vantaggiato C, Nobile M, Clementi E
. A systematic review of the antidepressant effects of glucagon-like peptide 1 (GLP-1) functional agonists: Further link between metabolism and psychopathology: Special Section on "Translational and Neuroscience Studies in Affective Disorders"..... J Affect Disord. 2019; 257.
DOI: 10.1016/j.jad.2019.05.044.
View
15.
Bhaskaran K, Douglas I, Forbes H, Dos-Santos-Silva I, Leon D, Smeeth L
. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014; 384(9945):755-65.
PMC: 4151483.
DOI: 10.1016/S0140-6736(14)60892-8.
View
16.
Jerlhag E, Egecioglu E, Dickson S, Douhan A, Svensson L, Engel J
. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol. 2007; 12(1):6-16.
DOI: 10.1111/j.1369-1600.2006.00041.x.
View
17.
Epstein L, Temple J, Neaderhiser B, Salis R, Erbe R, Leddy J
. Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behav Neurosci. 2007; 121(5):877-86.
PMC: 2213752.
DOI: 10.1037/0735-7044.121.5.877.
View
18.
Adams W, Sussman J, Kaur S, Dsouza A, Kieffer T, Winstanley C
. Long-term, calorie-restricted intake of a high-fat diet in rats reduces impulse control and ventral striatal D2 receptor signalling - two markers of addiction vulnerability. Eur J Neurosci. 2015; 42(12):3095-104.
DOI: 10.1111/ejn.13117.
View
19.
Jerlhag E
. Systemic administration of ghrelin induces conditioned place preference and stimulates accumbal dopamine. Addict Biol. 2008; 13(3-4):358-63.
DOI: 10.1111/j.1369-1600.2008.00125.x.
View
20.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M
. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015; 373(1):11-22.
DOI: 10.1056/NEJMoa1411892.
View